2nd PEGS Europe

Bitte beachten Sie: Die Konferenz wird in englischer Sprache gehalten und es wird keine simultane Übersetzung angeboten.

Due to last year's success BIOTECHNICA and Cambridge Healthtech Institute (CHI) are again featuring an important life science conference.

At PEGS Europe 2010 delegates will hear over 50 presentations from international researchers, with the ability to move between two concurrent tracks to attend presentations of specific interest to them. There are also numerous other learning and networking opportunities ranging from Pre-Conference Short Courses to networking receptions and other social events.

Keynote Presentations

• Exploiting Nanobody® Advantages to Target Challenging Proteins: From Discovery to in vivo Proof-of-Concept for an Anti-GPCR Nanobody (Debbie Law, Ph.D., Chief Scientific Officer, Research, Ablynx NV)
• Protein Expression in Mammalian Cells: Past Perspective, Future Potential (John-Slough Birch, Ph.D., CSO, Biopharmaceuticals, Lonza Group)
• Incorporation of Developability and Manufacturability in Therapeutic Antibody Discovery (Bernhardt L. Trout, Ph.D., Director, Novartis-MIT Center for Continuous Manufacturing)
  

Programs

• Novel Antibody Constructs and Alternative Scaffolds
• Protein Expression and Cell Line Development
• Empowered Bispecific Antibodies and Antibody-Drug Conjugates
• Difficult Protein Expression and Purification

Information and registration
For more information and registration please visit www.PEGSummitEurope.com  

Become an exhibitor
Due to last year's success we feature again a joint pavilion for PEGS Europe within the exhibition hall. Become an exhibitor!

Conference sponsorships
There are a number of sponsorships available for PEGS Europe. Opportunities include podium presentations in the session room, refreshment breaks, corporate branding and literature distribution. Any package can be customized to meet with your objectives and budget.
To learn more, please contact Carol Dinerstein (email: Please click here or +1 781-972-5471).